Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.

Not Invested

Community Contributor

Published

09 Mar 25

Updated

10 Mar 25

White_valkyrie's Fair Value

US$460.00

97.9% undervalued

18 Mar

US$9.49

-29.9%

-10.9%

-29.9%

-10.9%

You can edit this narrative until May 14 2:40 AM. Then, changes will post as Updates.

Author's Valuation

US$46097.9% undervalued

White_valkyrie's Fair Value

Shared on10 Mar 25

White_valkyrie made no meaningful changes to valuation assumptions.

US$460

97.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

74.51%

Biotech revenue growth rate

9.12%